Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (321-330 of 635) with videos related to

Pageof 64
Sort By:
Circulation. Cardiovascular Interventions|April 11, 2018
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Elliott M Groves, Deepak L Bhatt, Philippe Gabriel Steg, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|November 27, 2013
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillationBenjamin A Steinberg, Dajuanicia N Holmes, Jonathan P Piccini, et al.
Journal of the American Heart Association|October 30, 2018
Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores: Findings From the ORBIT-AF I and II RegistriesLarry R Jackson, Sunghee Kim, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|December 6, 2017
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysGordon F Tomaselli, Kenneth W Mahaffey, Adam Cuker, et al.
American Heart Journal|August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF TrialSreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
Journal of the American Heart Association|April 15, 2018
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) RegistryMarat Fudim, Peter R Liu, Peter Shrader, et al.
Journal of the American Heart Association|December 17, 2015
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac SurgerySean van Diepen, Pierluigi Tricoci, Mohua Podder, et al.
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Pageof 64

Showing results (321-330 of 635) with videos related to

Sort By:
Pageof 64
Circulation. Cardiovascular Interventions|April 11, 2018
Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Elliott M Groves, Deepak L Bhatt, Philippe Gabriel Steg, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|November 27, 2013
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillationBenjamin A Steinberg, Dajuanicia N Holmes, Jonathan P Piccini, et al.
Journal of the American Heart Association|October 30, 2018
Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores: Findings From the ORBIT-AF I and II RegistriesLarry R Jackson, Sunghee Kim, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|December 6, 2017
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysGordon F Tomaselli, Kenneth W Mahaffey, Adam Cuker, et al.
American Heart Journal|August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF TrialSreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
Journal of the American Heart Association|April 15, 2018
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) RegistryMarat Fudim, Peter R Liu, Peter Shrader, et al.
Journal of the American Heart Association|December 17, 2015
Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac SurgerySean van Diepen, Pierluigi Tricoci, Mohua Podder, et al.
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Pageof 64